BIO International Convention 2026 is the largest global gathering for biotechnology, drawing tens of thousands of industry leaders, investors, and policymakers. Four days of BIO Partnering, exhibition, and sessions cover therapeutics, AI and digital health, policy, and deal-making. It represents the full biotech ecosystem, from startups and pharma to academia and government.
The BIO International Convention is the biotechnology industry’s largest annual event; BIO 2026 runs June 22–25, 2026 at the San Diego Convention Center and brings together roughly 20,000 industry leaders for a multi‑track program, large exhibition and intensive partnering. It features 130+ sessions across 18 focus areas, curated summits (AI Summit, BioProcess Theater, Start‑Up Stadium) and the BIO Partnering™ system to facilitate one‑on‑one meetings and dealmaking.
CEOs / Founders / Executive leadership, Business development / BD / Licensing, R&D scientists and translational researchers, Product / portfolio / program managers, Investors / VCs / corporate venture teams, Regulatory, policy and reimbursement professionals, Academic researchers and tech transfer offices, Students and early-career life-science professionals
Business and scientific leaders in the biotechnology and pharmaceutical ecosystem looking to source partners, investors, customers or scientific collaborators; BD and licensing professionals; startup founders seeking visibility and investor meetings; academics and policy/regulatory professionals tracking industry trends and partnerships.
Individuals or vendors whose products/services are unrelated to life sciences and biotech (limited relevance), or attendees seeking narrowly focused hands‑on laboratory training—BIO is a large industry conference focused on networking, partnering, scientific/business programs and exhibitions rather than extended lab workshops.
